T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+12.27%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$668B
AUM Growth
+$46.4B
Cap. Flow
-$8.06B
Cap. Flow %
-1.21%
Top 10 Hldgs %
28.47%
Holding
3,021
New
64
Increased
1,712
Reduced
925
Closed
96

Sector Composition

1 Technology 30.27%
2 Healthcare 17.75%
3 Financials 11.3%
4 Consumer Discretionary 11.17%
5 Communication Services 8.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRDF icon
2751
Cardiff Oncology
CRDF
$138M
$61K ﹤0.01%
36,500
DXLG icon
2752
Destination XL Group
DXLG
$68.4M
$61K ﹤0.01%
10,960
+825
+8% +$4.59K
PED icon
2753
PEDEVCO
PED
$54.9M
$61K ﹤0.01%
57,500
-22,300
-28% -$23.7K
XBIT icon
2754
XBiotech
XBIT
$86.9M
$61K ﹤0.01%
17,600
NAGE
2755
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
$61K ﹤0.01%
39,300
SYRS
2756
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$61K ﹤0.01%
22,550
+10,400
+86% +$28.1K
AKBA icon
2757
Akebia Therapeutics
AKBA
$780M
$60K ﹤0.01%
105,500
-61,400
-37% -$34.9K
AQMS icon
2758
Aqua Metals
AQMS
$5.3M
$60K ﹤0.01%
299
-260
-47% -$52.2K
CLOV icon
2759
Clover Health Investments
CLOV
$1.6B
$60K ﹤0.01%
69,854
-153,349
-69% -$132K
SLQT icon
2760
SelectQuote
SLQT
$346M
$58K ﹤0.01%
26,400
-87,441
-77% -$192K
DNMR
2761
DELISTED
Danimer Scientific, Inc.
DNMR
$58K ﹤0.01%
416
+9
+2% +$1.26K
SMRT icon
2762
SmartRent
SMRT
$273M
$57K ﹤0.01%
22,242
-62,801
-74% -$161K
STTK icon
2763
Shattuck Labs
STTK
$88.6M
$57K ﹤0.01%
19,300
SVRA icon
2764
Savara
SVRA
$638M
$57K ﹤0.01%
28,960
FFAI
2765
Faraday Future Intelligent Electric Inc. Common Stock
FFAI
$250M
$57K ﹤0.01%
17
+7
+70% +$23.5K
CRBU icon
2766
Caribou Biosciences
CRBU
$172M
$56K ﹤0.01%
+10,546
New +$56K
IVVD icon
2767
Invivyd
IVVD
$260M
$56K ﹤0.01%
46,639
-466,564
-91% -$560K
LPCN icon
2768
Lipocine
LPCN
$15.9M
$56K ﹤0.01%
10,271
-591
-5% -$3.22K
PHUN icon
2769
Phunware
PHUN
$54.3M
$56K ﹤0.01%
1,572
+634
+68% +$22.6K
STIM icon
2770
Neuronetics
STIM
$233M
$56K ﹤0.01%
19,100
EXPR
2771
DELISTED
Express, Inc.
EXPR
$56K ﹤0.01%
3,533
VBIV
2772
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$55K ﹤0.01%
5,997
CSSE
2773
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$53K ﹤0.01%
26,300
SRT
2774
DELISTED
Startek Inc.
SRT
$53K ﹤0.01%
12,800
ATHX
2775
DELISTED
Athersys, Inc. Common Stock
ATHX
$53K ﹤0.01%
42,376